Loading...

KYTX KYVERNA THERAPEUTICS INC Earnings Reports 8-K Filing

KYVR

KYTX

KYVERNA THERAPEUTICS INC

(KYTX)

2026 8-K

CFO Appointment

Business Update Issued

Management Change

Positive Trial Results

Positive Trial Results

Positive Clinical Data

Quarterly Earnings Update

Board Appointments

Management Change

Management Change

Stock Offering Details

Positive Data Release

Positive Trial Results

Business Update

Loan Agreement Funded

Positive Trial Results

Positive Data Release

Financial Statements

Stock Sale Agreement

Financial Results

Management Appointment

Strategic Priorities

Management Change

Financial Update

Director Appointment

Management Changes

External Links:

On March 26, 2026, Kyverna Therapeutics, Inc. reported its fourth quarter and full year financial results for 2025, highlighting business achievements. The details are provided in their press release, which is included in the 8-K filing.

AI Assistant

KYVERNA THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.